Hines has plans to place a larger emphasis on investing in more life sciences sector opportunities. This market outlook is supported by the heightened focus the pandemic has placed on life sciences within the commercial real estate industry. To meet the new demand, Hines plans to be a leading investor and developer by providing more purpose-built life sciences facilities in growing markets with state-of-the-art, operator-driven design and amenities.
“The life sciences sector is experiencing an era of unprecedented growth driven by a rise in both public and private funding combined with a post-pandemic sense of urgency and market opportunity,” said David Steinbach, global CIO at Hines. “As this industry surges, it is pivotal that developers keep pace by delivering spaces that are as innovative as the tenants occupying them. Hines is dedicated to delivering purpose-built facilities that meet the physical, functional and technological needs of the occupiers.”
Hine
